Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Sertraline's action occurs primarily in the central nervous system through inhibition of the serotonin transporter protein
SLM+ is the key to unlocking modern results from legacy medications
doi: 10.3389/fendo.2025.1650729 Received 20 June 2025 Accepted 18 September 2025 Published 01 October 2025 Volume 16 - 2025 Edited by Maria Gazouli, National and Kapodistrian University of Athens, Greece Reviewed by Xiaohang Wang, Affiliated Hospital of Yangzhou University, China Junqing Lin, Shanghai Jiao Tong University, China Guangda He, Chinese Academy of Medical Sciences and Peking Union Medical College, China Updates Copyright 2025 Niu, Chen, Wu, Wang, Xu, Yin and Zhao
Glucagon-like Peptide-1 Receptor: Mechanisms and Advances in Therapy. Signal Transduction and Targeted Therapy, vol
US$ 22.40
US$ 21.73
US$ 20.58
US$ 20.59
US$ 22.86
